This Article Full Text Full Text (PDF) All Versions of this Article: 109/18/2181    most recent 01.CIR.0000127960.28627.75v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shamsuzzaman, A. S.M. Articles by Somers, V. K. Search for Related Content PubMed PubMed Citation Articles by Shamsuzzaman, A. S.M. Articles by Somers, V. K. Pubmed/NCBI databases Substance via MeSH Related Collections Obesity Pathophysiology Risk Factors Calcium cycling/excitation-contraction coupling Growth factors/cytokines

(Circulation. 2004;109:2181-2185.)
© 2004 American Heart Association, Inc.

Clinical Investigation and Reports

Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans

Abu S.M. Shamsuzzaman, MBBS, PhD; Mikolaj Winnicki, MD, PhD; Robert Wolk, MD, PhD; Anna Svatikova, BA; Bradley G. Phillips, BSc, PharmD; Diane E. Davison, RN, MA; Peter B. Berger, MD; Virend K. Somers, MD, PhD

From the Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minn (A.S.M.S., M.W., R.W., A.S., D.E.D., V.K.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (M.W.); Division of Clinical and Administrative Pharmacy, University of Iowa, Iowa City (B.G.P.); and Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (P.B.B.).

Correspondence to Virend K. Somers, MD, DPhil, Division of Cardiovascular Diseases, Mayo Clinic Rochester, 200 First St SW, Rochester, MN 55905. E-mail somers.virend{at}mayo.edu

Received October 7, 2003; revision received February 5, 2004; accepted February 6, 2004.

Background— C-reactive protein (CRP) is synthesized from the liver and is regulated by cytokines, especially interleukin-6. Leptin, the adipocyte-derived protein product of the ob gene, is related to amount of body fat. The long form of the leptin receptor resembles cytokine receptors, which include the interleukin-6 receptor. Both leptin and CRP may be increased in women, in obesity, and in inflammation, and both have been linked to cardiovascular pathophysiological processes and increased cardiovascular risk. We tested the hypothesis that leptin is associated with CRP levels independently of the influences of gender, body mass index (BMI), waist-to-hip ratio, and other variables.

Methods and Results— We studied 100 healthy volunteers (48 men, and 52 women). For all subjects, leptin was independently associated with CRP after adjustment for age, gender, BMI, waist-to-hip ratio, smoking, and alcohol consumption (F=12.39, P=0.0007). There was a strong and significant positive relationship between leptin and CRP in both women (R=0.61, P<0.0001) and men (R=0.55, P<0.0001) considered separately. The association between leptin and CRP was significant even after adjustment for age, BMI, waist-to-hip ratio, smoking, and alcohol consumption in women (F=7.13, P=0.01) and men (F=5.69, P=0.02). When only subjects with BMI <25 kg/m² were considered (n=47), CRP was not linked to BMI (R=0.02, P=0.96), but a significant association between leptin and CRP was still evident (R=0.55, P<0.0001).

Conclusions— Leptin and CRP levels are independently associated in normal humans, providing further evidence linking metabolic and inflammatory cardiovascular disease mechanisms.

Key Words: C-reactive protein • cardiovascular diseases • inflammation • leptin • obesity • risk factors

This article has been cited by other articles:

				T Lappalainen, M Kolehmainen, U Schwab, L Pulkkinen, D E Laaksonen, R Rauramaa, M Uusitupa, and H Gylling Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study Eur. J. Endocrinol., March 1, 2008; 158(3): 333 - 341. [Abstract] [Full Text] [PDF]

				R. J Kaaja Metabolic syndrome and the menopause Menopause Int, March 1, 2008; 14(1): 21 - 25. [Abstract] [Full Text] [PDF]

				L. A. Viikari, R. K. Huupponen, J. S. A. Viikari, J. Marniemi, C. Eklund, M. Hurme, T. Lehtimaki, M. Kivimaki, and O. T. Raitakari Relationship between Leptin and C-Reactive Protein in Young Finnish Adults J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4753 - 4758. [Abstract] [Full Text] [PDF]

				J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study Circulation, November 13, 2007; 116(20): 2275 - 2279. [Abstract] [Full Text] [PDF]

				S. Djurovic, K. E. Berge, B. Birkenes, O. Braaten, and L. Retterstol The effect of red wine on plasma leptin levels and vasoactive factors from adipose tissue: A randomized crossover trial Alcohol Alcohol., November 1, 2007; 42(6): 525 - 528. [Abstract] [Full Text] [PDF]

				P. Singh, M. Hoffmann, R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): e302 - e307. [Abstract] [Full Text] [PDF]

				J. D. Knudson, G. M. Dick, and J. D. Tune Adipokines and Coronary Vasomotor Dysfunction Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736. [Abstract] [Full Text] [PDF]

				E. Oda Criteria for diagnosing the metabolic syndrome. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1251 - 1252. [Full Text] [PDF]

				E. Oda The metabolic syndrome (emperor) wears no clothes: response to kahn. Diabetes Care, November 1, 2006; 29(11): 2566 - 2566. [Full Text] [PDF]

				A. U. Momin, N. Melikian, A. M. Shah, D. J. Grieve, S. B. Wheatcroft, L. John, A. El Gamel, J. B. Desai, T. Nelson, C. Driver, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance Eur. Heart J., October 1, 2006; 27(19): 2294 - 2299. [Abstract] [Full Text] [PDF]

				R. Wolk and V. K. Somers Leptin and vascular function: friend or foe? Eur. Heart J., October 1, 2006; 27(19): 2263 - 2265. [Full Text] [PDF]

				D M Wunder, M Yared, N A Bersinger, D Widmer, R Kretschmer, and M H Birkhauser Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. Eur. J. Endocrinol., July 1, 2006; 155(1): 137 - 142. [Abstract] [Full Text] [PDF]

				S. Mora, I-M. Lee, J. E. Buring, and P. M Ridker Association of Physical Activity and Body Mass Index With Novel and Traditional Cardiovascular Biomarkers in Women JAMA, March 22, 2006; 295(12): 1412 - 1419. [Abstract] [Full Text] [PDF]

				S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]

				B. Canavan, R. O. Salem, S. Schurgin, P. Koutkia, I. Lipinska, M. Laposata, and S. Grinspoon Effects of Physiological Leptin Administration on Markers of Inflammation, Platelet Activation, and Platelet Aggregation during Caloric Deprivation J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5779 - 5785. [Abstract] [Full Text] [PDF]

				S. Devaraj, G. O'Keefe, and I. Jialal Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554. [Abstract] [Full Text] [PDF]

				J. Gomez-Ambrosi, J. Salvador, C. Silva, F. Rotellar, M. J. Gil, J. A. Cienfuegos, and G. Fruhbeck Leptin Therapy Does Not Affect Inflammatory Markers J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3803 - 3803. [Full Text] [PDF]

				C. Kasapis and P. D. Thompson The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers: A Systematic Review J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1563 - 1569. [Abstract] [Full Text] [PDF]

				A. H. Berg and P. E. Scherer Adipose Tissue, Inflammation, and Cardiovascular Disease Circ. Res., May 13, 2005; 96(9): 939 - 949. [Abstract] [Full Text] [PDF]

				D.M. Wunder, R. Kretschmer, and N.A. Bersinger Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles Hum. Reprod., May 1, 2005; 20(5): 1266 - 1271. [Abstract] [Full Text] [PDF]

				G. Matarese, S. Moschos, and C. S. Mantzoros Leptin in Immunology J. Immunol., March 15, 2005; 174(6): 3137 - 3142. [Abstract] [Full Text] [PDF]

				M. von Eynatten, J. G. Schneider, S. Hadziselimovic, A. Hamann, A. Bierhaus, P. P. Nawroth, and K. A. Dugi Adipocytokines as a Novel Target for the Anti-inflammatory Effect of Atorvastatin in Patients With Type 2 Diabetes Diabetes Care, March 1, 2005; 28(3): 754 - 755. [Full Text] [PDF]

				J. L. Chan, J. Bullen, V. Stoyneva, A. M. DePaoli, C. Addy, and C. S. Mantzoros Recombinant Methionyl Human Leptin Administration to Achieve High Physiologic or Pharmacologic Leptin Levels Does Not Alter Circulating Inflammatory Marker Levels in Humans with Leptin Sufficiency or Excess J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1618 - 1624. [Abstract] [Full Text] [PDF]

				K. Tsuda, I. Nishio, A. S.M. Shamsuzzaman, M. Winnicki, R. Wolk, A. Svatikova, D. E. Davison, V. K. Somers, B. G. Phillips, and P. B. Berger Leptin, C-Reactive Protein, and Nitric Oxide Production in Healthy Humans * Response Circulation, September 28, 2004; 110(13): e330 - e330. [Full Text] [PDF]